Revised model of coagulation

Slides:



Advertisements
Similar presentations
Disseminated Intravascular Coagulation
Advertisements

 An acquired syndrome characterized by systemic intravascular coagulation  Coagulation is always the initial event.  Most morbidity and mortality depends.
Coagulation Just the basics.... Three steps Vasoconstriction Platelet plug formation Fibrin clot formation.
From Blood to Host Defense Hemostasis and Clotting
TACTIC PROJECT 2: THE ROLE OF FACTOR XI IN TIC LEAD INVESTIGATOR: SAULIUS BUTENAS (UNIVERSITY OF VERMONT) CO-INVESTIGATOR: JAMES H MORRISSEY (UNIVERSITY.
HEMOSTASIS. Hemostasis a body mechanism to stop traumatic bleeding to prevent spontaneous bleeding to keep the fluidity of blood.
Blood coagulation involves a biological amplification system in which relatively few initiation substances sequentially activate by proteolysis a cascade.
Coagulation Cascade Ahmad Shihada Silmi Msc,FIBMS IUG Faculty of Science Medical Technology Dept.
Blood coagulation and fibrinolysis Professor Asim K. Duttaroy University of Oslo.
Tabuk University Faculty of Applied Medical Sciences Department Of Medical Lab. Technology 3 rd Year – Level 5 – AY
Coagulation Mechanisms
Anticoagulants, Thrombolytic Agents and Antiplatelet Drugs
PHYSIOLOGIC CONTROL OF HEMOSTASIS MLAB Coagulation Keri Brophy-Martinez.
MLAB Coagulation Keri Brophy-Martinez Fibrinolytic System.
Coagulation and fibrinolysis
Hemodynamics 2.
How we clot (and how not to clot) Sema Yilmaz, MD, Assoc. Prof.
IN THE NAME OF GOD Disseminated Intravascular Coagulation Dr.h-kayalhaAnesthesiologist.
Coagulation ICU – RLH Mike Cunningham 11 th December 2008.
From: Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®) Anesthes. 2003;98(6):
More detailed view of the process shown in Fig
HAEMOSTASIS AND THROMBOSIS Regulation of coagulation
Immune pathogenesis of apoptosis of CD34 multipotential hematopoietic cells in acquired aplastic anemia. Antigens are presented to T lymphocytes by antigen-presenting.
Anesthes. 2013;118(6): doi: /ALN.0b013e318289bcba Figure Legend:
Immunoglobulin heavy-chain (IGHC) gene complex
Kaplan-Meier plots of time from platelet transfusion to first Grade 2 or higher bleeding for each platelet characteristic. A. Time from first platelet.
Activation of the Hemostatic System During Cardiopulmonary Bypass
Overview of hybrid capture preparation for sequencing
(Reprinted by permission from Macmillan Publishers Ltd
(From Beutler E, Meerkreebs G,705 with permission from the Massachusetts Medical Society.) Source: Chapter 42. Disorders of Iron Metabolism, Williams Hematology,
Effector mechanisms by which drugs mediate a positive direct antiglobulin test. Relationships of drug, antibody-combining site, and red blood cell membrane.
Estimated fraction of the various forms of secondary ITP based on clinical experience of the authors. The incidence of Helicobacter pylori (HP) ranges.
(Used with permission from Lichtman’s Atlas of Hematology, www
(Reproduced with permission from Lau TL, Kim C, Ginsberg MH, et al
Illumina library construction and sequencing process
Copyright © 2003 American Medical Association. All rights reserved.
Platelet calcium homeostasis
Hypercoagulable States
Regulation of blood coagulation
A. Antiphospholipid antibody syndrome
Models of Fibrin Generation
Model of the function of the protein C anticoagulant pathway
(Used with permission from Lichtman’s Atlas of Hematology, www
(Used with permission from Lichtman's Atlas of Hematology, www
Evaluation of patients for inherited abnormalities in platelet number or function. The major and well-recognized entities are shown here. A reduced platelet.
What is a Blood Clot? 9/18/2018 MEDC 604 Anti-coagulants.
Hemodynamic disorders (1 of 3)
and anti-thrombotic pharmocology Tom Williams
Coagulation and Anti-coagulation
Modulation of hemostatic mechanisms in bacterial infectious diseases
Anti-Coagulants Physical Process of Clotting
Perioperative management of the bleeding patient
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Coagulation, fibrinolysis, and platelet activation in patients undergoing open and endovascular repair of abdominal aortic aneurysm  Robert S.M. Davies,
Coagulation and innate immune responses: can we view them separately?
Figure 1 The coagulation system
Clinical Aspects of Biochemistry
Thrombin During Cardiopulmonary Bypass
Thrombosis and Inflammatory Bowel Disease
Naturally Occurring Inhibitors
Chapter 15 Arterial and Venous Thrombosis and Thrombolysis
Antifibrinolytic therapy: new data and new concepts
A simplified representation of the coagulation cascade.
The alveolar compartment in idiopathic pulmonary fibrosis (IPF).
Hemostasis Hemostasis depends on the integrity of Blood vessels
Section B: Science update
Editorial III British Journal of Anaesthesia
Coagulation cascade influenced by renal dysfunction and mechanisms of action of oral anticoagulants. Coagulation cascade influenced by renal dysfunction.
Effects of vitamin K antagonists (VKA), such as warfarin, low-molecular-weight heparin (LMWH), and dabigatran, on the coagulation pathway. Effects of vitamin.
Presentation transcript:

Revised model of coagulation Revised model of coagulation. Schematic overview of the coagulation reactions in which several revisions have been made as compared to the classic cascade model of coagulation. The tissue factor–factor VIIa complex of the extrinsic pathway also activates factor IX, and thrombin activates factor XI, in a positive feedback loop. The factor IX–dependent amplification of factor Xa generation is necessary for hemostatic fibrin formation at low tissue factor concentrations, because tissue factor–factor VIIa–mediated factor X activation is inhibited by tissue factor pathway inhibitor (TFPI). Procoagulant extrinsic pathway components are indicated in black, the part of the intrinsic coagulation pathway that is not necessary for hemostasis is indicated in gray. Anticoagulant mediators are indicated in red. AP, antiplasmin; APC, activated protein C; AT, antithrombin; Hep, heparin; HK, high-molecular-weight kininogen; PAI, plasminogen activator inhibitor; PZ, protein Z; TAFI, thrombin-activatable fibrinolysis inhibitor; TF, tissue factor; Tm, thrombomodulin; tPA, tissue plasminogen activator; uPA, urokinase plasminogen activator; ZPI, protein Z–dependent protease inhibitor. Source: Molecular Biology and Biochemistry of the Coagulation Factors and Pathways of Hemostasis, Williams Hematology, 9e Citation: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M. Williams Hematology, 9e; 2015 Available at: http://hemonc.mhmedical.com/DownloadImage.aspx?image=/data/books/1581/kau_ch113_f028.png&sec=108080009&BookID=1581&ChapterSecID=108079516&imagename= Accessed: September 29, 2017 Copyright © 2017 McGraw-Hill Education. All rights reserved